MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517042870 A) filed by The Translational Genomics Research Institute; and University Of Utah Research Foundation, Phoenix, on May 2, for 'phenyl oxy amide kinase inhibitors.'
Inventor(s) include Kasibhatla, Srinivas Rao; Kaadige, Mohan; Thode, Trason; Sharma, Sunil; Weston, Alexis; Welm, Alana; and Fornetti, Jaime.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "Compounds having activity as kinase inhibitors are provided. The compounds have Structure (I), or a stereoisomer, tautomer, or salt thereof, wherein, R1, R3, and m are as defined herein. Methods associated with preparation and use of such compounds, pharmaceutical compositions comprising such compounds and methods of use of the same for treatment of diseases and disorders are also provided."
The patent application was internationally filed on Oct. 04, 2023, under International application No.PCT/US2023/075937.
Disclaimer: Curated by HT Syndication.